Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Blinded, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam for Inhalation (AI) in Cystic Fibrosis Patient With Lung Disease Due to P. Aeruginosa Infection

NCT01055847 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT01055847
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01055847 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Blinded, Multicenter, Randomized, Placebo-Controlled Trial With Aztreonam for Inhalation (AI) in Cystic Fibrosis Patient With Lung Disease Due to P. Aeruginosa Infection
Lead sponsor
Gilead Sciences
Phase
Phase 2
Overall status
Completed
Start date
June 30, 2003
Completion date
September 30, 2004
Enrollment
105 (actual)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

cf, cystic fibrosis, lung infection, pseudomonas aeruginosa